Skip to main content
. 2020 Jul 21;26(8):1000–1009. doi: 10.1002/lt.25738

Table 2.

Recipient Demographics

Overall (n = 100) Graft Type Presence of Cholangiopathy
DBD (n = 65) DCD (n = 35) P Value No Cholangiopathy (n = 88) Cholangiopathy (n = 12) P Value
Age, years 55.7 ± 11 55.7 ± 11.4 55.9 ± 10.4 0.98 55.6 ± 11 56.4 ± 10 0.82
Sex, male 64 (64.0) 38 (58.5) 26 (74.3) 0.09 53 (60.2) 11 (91.7) 0.05
BMI, kg/m2 27.8 ± 5.6 27.3 ± 5.6 28.6 ± 5.5 0.18 27.8 ± 5.8 27.6 ± 4.2 0.92
UKELD 54 (52‐58) 55 (52‐58) 54 (52‐57) 0.12 54 (52‐58) 53 (51‐55) 0.1
Etiology
ALD 23 (23.0) 15 (23.1) 8 (22.9) 22 (25.0) 1 (8.3)
NAFLD 26 (26.0) 13 (20.0) 13 (37.1) 25 (28.4) 1 (8.3)
PSC 16 (16.0) 12 (18.5) 4 (11.4) 12 (13.6) 4 (33.3)
HCV 12 (12.0) 6 (9.2) 6 (17.1) 9 (10.2) 3 (25.0)
PBC 5 (5.0) 4 (6.2) 1 (2.9) 5 (5.7) 0 (0.0)
ALF 2 (2.0) 2 (3.1) 0 (0.0) 2 (2.3) 0 (0.0)
HAT 2 (2.0) 2 (3.1) 0 (0.0) 1 (1.1) 1 (8.3)
Others 14 (14.0) 11 (16.9) 3 (8.6) 12 (13.6) 2 (16.7)
Malignancy 20 (20.0) 9 (13.8) 11 (31.4) 0.07 14 (15.9) 6 (50) 0.002
Retransplantation 6 (6.0) 6 (9.2) 0 (0.0) 5 (5.7) 1 (8.3) 0.55
IC 12 (12.0) 4 (6.2) 8 (22.9) 0.02

Data are given as n (%), mean ± SD, or median (IQR).